1,2-dimethylhydrazine decreases expression ISO RGD:1550582 6480464 1, 2-Dimethylhydrazine results in decreased expression of SFRP2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1550582 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFRP2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1550582 6480464 Estradiol results in decreased expression of SFRP2 mRNA CTD PMID:14664709 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SFRP2 mRNA CTD PMID:26945725 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550582 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFRP2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1345643 6480464 Tetrachlorodibenzodioxin results in increased expression of SFRP2 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550582 6480464 Tetrachlorodibenzodioxin results in decreased expression of SFRP2 mRNA CTD PMID:32553695 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of SFRP2 mRNA CTD PMID:17109745 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1550582 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SFRP2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1550582 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SFRP2 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345643 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SFRP2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SFRP2 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1550582 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SFRP2 mRNA CTD PMID:23519560 4,4'-sulfonyldiphenol increases methylation ISO RGD:1345643 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SFRP2 gene CTD PMID:31601247 4-hydroperoxycyclophosphamide decreases expression ISO RGD:1550582 6480464 perfosfamide results in decreased expression of SFRP2 mRNA CTD PMID:19429390 4-hydroxyphenyl retinamide decreases expression ISO RGD:1550582 6480464 Fenretinide results in decreased expression of SFRP2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:1345643 6480464 Decitabine results in increased expression of SFRP2 mRNA, Decitabine results in increased expression of SFRP2 protein CTD PMID:19387464 , PMID:29320940 5-aza-2'-deoxycytidine increases methylation ISO RGD:1345643 6480464 Decitabine results in increased methylation of SFRP2 promoter CTD PMID:29320940 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1345643 6480464 Decitabine results in decreased methylation of SFRP2 promoter CTD PMID:19387464 5-aza-2'-deoxycytidine affects methylation ISO RGD:1345643 6480464 Decitabine affects the methylation of SFRP2 promoter CTD PMID:17848950 , PMID:17882284 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1345643 6480464 [Decitabine affects the methylation of SFRP2 promoter] which affects the expression of SFRP2 mRNA more ... CTD PMID:17923031 more ... 5-fluorouracil decreases expression ISO RGD:1345643 6480464 Fluorouracil results in decreased expression of SFRP2 mRNA CTD PMID:24737281 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SFRP2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression ISO RGD:1550582 6480464 Propylthiouracil results in increased expression of SFRP2 mRNA CTD PMID:36706583 7,12-dimethyltetraphene decreases expression ISO RGD:1550582 6480464 9 more ... CTD PMID:32553695 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SFRP2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1345643 6480464 Acrylamide results in decreased expression of SFRP2 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:1345643 6480464 Aflatoxin B1 results in decreased methylation of SFRP2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1345643 6480464 Aflatoxin B1 results in increased expression of SFRP2 mRNA CTD PMID:28943387 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of SFRP2 mRNA CTD PMID:17109745 all-trans-retinoic acid decreases expression ISO RGD:1345643 6480464 Tretinoin results in decreased expression of SFRP2 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SFRP2 mRNA CTD PMID:20488242 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SFRP2 mRNA CTD PMID:16483693 androgen antagonist multiple interactions EXP 6480464 [Pesticides co-treated with Phthalic Acids co-treated with Androgen Antagonists] results in increased expression of SFRP2 mRNA CTD PMID:29945228 antirheumatic drug increases expression ISO RGD:1345643 6480464 Antirheumatic Agents results in increased expression of SFRP2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of SFRP2 mRNA CTD PMID:17483316 arotinoid acid multiple interactions ISO RGD:1345643 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane affects methylation ISO RGD:1345643 6480464 Arsenic affects the methylation of SFRP2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1345643 6480464 Arsenic affects the methylation of SFRP2 gene CTD PMID:25304211 arsenite(3-) increases expression ISO RGD:1550582 6480464 arsenite results in increased expression of SFRP2 mRNA CTD PMID:33053406 arsenite(3-) increases methylation ISO RGD:1345643 6480464 arsenite results in increased methylation of SFRP2 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:1345643 6480464 Arsenic Trioxide results in decreased expression of SFRP2 mRNA CTD PMID:22521957 , PMID:26705709 atrazine multiple interactions ISO RGD:1345643 6480464 [Atrazine co-treated with Arsenates] results in increased expression of SFRP2 mRNA CTD PMID:18585445 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene CTD PMID:33854195 benzo[a]pyrene decreases expression ISO RGD:1550582 6480464 Benzo(a)pyrene metabolite results in decreased expression of SFRP2 mRNA, Benzo(a)pyrene results in decreased expression of SFRP2 mRNA CTD PMID:21569818 , PMID:32553695 benzo[a]pyrene affects methylation ISO RGD:1345643 6480464 Benzo(a)pyrene affects the methylation of SFRP2 exon, Benzo(a)pyrene affects the methylation of SFRP2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1345643 6480464 Benzo(a)pyrene results in increased methylation of SFRP2 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1345643 6480464 Benzo(a)pyrene results in decreased methylation of SFRP2 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1550582 6480464 Benzo(a)pyrene results in increased expression of SFRP2 mRNA CTD PMID:22228805 Benzo[ghi]perylene increases expression ISO RGD:1550582 6480464 1, 12-benzoperylene results in increased expression of SFRP2 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of SFRP2 mRNA CTD PMID:17109745 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1550582 6480464 Mustard Gas results in decreased expression of SFRP2 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1345643 6480464 Diethylhexyl Phthalate results in decreased expression of SFRP2 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1345643 6480464 Diethylhexyl Phthalate results in increased expression of SFRP2 protein CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SFRP2 mRNA CTD PMID:22504913 bisphenol A decreases methylation ISO RGD:1345643 6480464 bisphenol A results in decreased methylation of SFRP2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1550582 6480464 bisphenol A results in decreased expression of SFRP2 mRNA CTD PMID:35278557 bisphenol A multiple interactions ISO RGD:1345643 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SFRP2 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SFRP2 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SFRP2 mRNA CTD PMID:25963729 , PMID:32145629 bisphenol A multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in increased expression of SFRP2 mRNA] CTD PMID:25963729 bisphenol F multiple interactions ISO RGD:1345643 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SFRP2 mRNA CTD PMID:28628672 bisphenol F decreases expression ISO RGD:1550582 6480464 bisphenol F results in decreased expression of SFRP2 mRNA CTD PMID:35278557 bromochloroacetic acid decreases expression ISO RGD:1550582 6480464 bromochloroacetic acid results in decreased expression of SFRP2 protein CTD PMID:21296659 cadmium atom multiple interactions ISO RGD:1550582 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of SFRP2 mRNA CTD PMID:31904401 cadmium dichloride increases expression ISO RGD:1345643 6480464 Cadmium Chloride results in increased expression of SFRP2 mRNA CTD PMID:12160620 cadmium dichloride multiple interactions ISO RGD:1550582 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of SFRP2 mRNA CTD PMID:31904401 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SFRP2 mRNA CTD PMID:33453195 carbon nanotube decreases expression ISO RGD:1550582 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1345643 6480464 CGP 52608 promotes the reaction [RORA protein binds to SFRP2 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:1345643 6480464 [4-(2-(5 more ... CTD PMID:34480604 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene CTD PMID:33854195 chlorpyrifos increases expression ISO RGD:1550582 6480464 Chlorpyrifos results in increased expression of SFRP2 mRNA CTD PMID:37019170 chrysene increases expression ISO RGD:1550582 6480464 chrysene results in increased expression of SFRP2 mRNA CTD PMID:26377693 cisplatin decreases expression ISO RGD:1550582 6480464 Cisplatin results in decreased expression of SFRP2 mRNA CTD PMID:21151649 copper atom increases expression EXP 6480464 Copper results in increased expression of SFRP2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of SFRP2 mRNA CTD PMID:30556269 corn oil decreases expression EXP 6480464 Corn Oil results in decreased expression of SFRP2 mRNA CTD PMID:22760963 cortisol multiple interactions ISO RGD:1345643 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SFRP2 mRNA CTD PMID:27523638 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of SFRP2 mRNA CTD PMID:25963729 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in increased expression of SFRP2 mRNA] CTD PMID:25963729 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SFRP2 mRNA CTD PMID:21865292 cytarabine increases expression ISO RGD:1345643 6480464 Cytarabine results in increased expression of SFRP2 mRNA CTD PMID:21198554 deguelin decreases expression ISO RGD:1345643 6480464 deguelin results in decreased expression of SFRP2 mRNA CTD PMID:19861542 dexamethasone multiple interactions ISO RGD:1550582 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of SFRP2 mRNA CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:1345643 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SFRP2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SFRP2 mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:1345643 6480464 Dexamethasone results in decreased expression of SFRP2 mRNA CTD PMID:25047013 diarsenic trioxide decreases expression ISO RGD:1345643 6480464 Arsenic Trioxide results in decreased expression of SFRP2 mRNA CTD PMID:22521957 , PMID:26705709 dibutyl phthalate decreases expression ISO RGD:1550582 6480464 Dibutyl Phthalate results in decreased expression of SFRP2 mRNA CTD PMID:21266533 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SFRP2 mRNA CTD PMID:21658437 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SFRP2 mRNA CTD PMID:33729688 diuron increases expression EXP 6480464 Diuron results in increased expression of SFRP2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1345643 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1550582 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of SFRP2 mRNA CTD PMID:21040762 doxorubicin decreases expression ISO RGD:1345643 6480464 Doxorubicin results in decreased expression of SFRP2 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:1550582 6480464 Doxorubicin results in decreased expression of SFRP2 mRNA CTD PMID:25896364 , PMID:28608983 entinostat decreases expression ISO RGD:1345643 6480464 entinostat results in decreased expression of SFRP2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1345643 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP2 mRNA CTD PMID:27188386 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SFRP2 mRNA CTD PMID:30307764 folic acid decreases expression ISO RGD:1550582 6480464 Folic Acid results in decreased expression of SFRP2 mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:1345643 6480464 Fonofos results in increased methylation of SFRP2 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:1345643 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SFRP2 gene CTD PMID:31601247 furan decreases methylation EXP 6480464 furan results in decreased methylation of SFRP2 gene CTD PMID:27387713 furan increases expression EXP 6480464 furan results in increased expression of SFRP2 mRNA CTD PMID:27387713 genistein increases expression EXP 6480464 Genistein results in increased expression of SFRP2 mRNA CTD PMID:17341692 genistein decreases expression EXP 6480464 Genistein results in decreased expression of SFRP2 mRNA CTD PMID:22504913 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene CTD PMID:33854195 hydrazine decreases expression ISO RGD:1550582 6480464 hydrazine results in decreased expression of SFRP2 mRNA CTD PMID:15282401 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene CTD PMID:33854195 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SFRP2 mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:1345643 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SFRP2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SFRP2 mRNA CTD PMID:28628672 L-ascorbic acid multiple interactions ISO RGD:1345643 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SFRP2 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:1345643 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SFRP2 mRNA CTD PMID:34480604 lead diacetate decreases expression ISO RGD:1550582 6480464 lead acetate results in decreased expression of SFRP2 mRNA CTD PMID:22613225 lipopolysaccharide increases expression ISO RGD:1550582 6480464 Lipopolysaccharides results in increased expression of SFRP2 mRNA CTD PMID:12057914 lithium chloride decreases expression ISO RGD:1345643 6480464 Lithium Chloride results in decreased expression of SFRP2 mRNA CTD PMID:20069066 lithium chloride multiple interactions ISO RGD:1345643 6480464 SFRP2 protein affects the reaction [Lithium Chloride results in increased expression of CTNNB1 mRNA] more ... CTD PMID:20069066 losartan decreases response to substance EXP 6480464 SFRP2 protein results in decreased susceptibility to Losartan CTD PMID:23875703 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SFRP2 mRNA CTD PMID:19564919 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SFRP2 mRNA CTD PMID:19564919 methylmercury chloride decreases expression ISO RGD:1345643 6480464 methylmercuric chloride results in decreased expression of SFRP2 mRNA CTD PMID:28001369 , PMID:34089799 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SFRP2 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SFRP2 mRNA CTD PMID:22129741 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of SFRP2 mRNA CTD PMID:23358140 panobinostat multiple interactions ISO RGD:1345643 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP2 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1345643 6480464 panobinostat results in decreased expression of SFRP2 mRNA CTD PMID:26272509 parathion increases methylation ISO RGD:1345643 6480464 Parathion results in increased methylation of SFRP2 promoter CTD PMID:22847954 phenylmercury acetate decreases expression ISO RGD:1345643 6480464 Phenylmercuric Acetate results in decreased expression of SFRP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345643 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1550582 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SFRP2 mRNA, [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of SFRP2 mRNA CTD PMID:23519560 , PMID:31904401 pioglitazone multiple interactions ISO RGD:1550582 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SFRP2 mRNA CTD PMID:27935865 rotenone increases expression ISO RGD:1345643 6480464 Rotenone results in increased expression of SFRP2 mRNA CTD PMID:36586010 SB 431542 multiple interactions ISO RGD:1345643 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 SCH 23390 decreases expression EXP 6480464 SCH 23390 results in decreased expression of SFRP2 mRNA CTD PMID:19564919 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SFRP2 mRNA CTD PMID:19564919 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SFRP2 mRNA CTD PMID:32721576 sodium arsenite decreases expression ISO RGD:1550582 6480464 sodium arsenite results in decreased expression of SFRP2 mRNA CTD PMID:20179202 tamoxifen increases expression ISO RGD:1550582 6480464 Tamoxifen results in increased expression of SFRP2 mRNA CTD PMID:25123088 terbufos increases methylation ISO RGD:1345643 6480464 terbufos results in increased methylation of SFRP2 promoter CTD PMID:22847954 tetraphene decreases expression ISO RGD:1550582 6480464 benz(a)anthracene results in decreased expression of SFRP2 mRNA CTD PMID:26377693 thalidomide increases expression ISO RGD:1550582 6480464 Thalidomide results in increased expression of SFRP2 mRNA CTD PMID:26217789 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene CTD PMID:33854195 titanium dioxide affects expression ISO RGD:1550582 6480464 titanium dioxide affects the expression of SFRP2 mRNA CTD PMID:23557971 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SFRP2 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1345643 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of SFRP2 mRNA more ... CTD PMID:17923031 more ... trichostatin A decreases expression ISO RGD:1345643 6480464 trichostatin A results in decreased expression of SFRP2 mRNA CTD PMID:24935251 , PMID:26272509 triclosan increases expression ISO RGD:1345643 6480464 Triclosan results in increased expression of SFRP2 mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:1550582 6480464 triptonide results in decreased expression of SFRP2 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1550582 6480464 troglitazone results in increased expression of SFRP2 mRNA CTD PMID:28973697 valproic acid increases expression ISO RGD:1345643 6480464 Valproic Acid results in increased expression of SFRP2 mRNA CTD PMID:24849673 valproic acid multiple interactions ISO RGD:1345643 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1345643 6480464 Valproic Acid results in decreased expression of SFRP2 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:1550582 6480464 Valproic Acid results in increased expression of SFRP2 mRNA CTD PMID:24896083 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SFRP2 mRNA CTD PMID:23034163 XAV939 multiple interactions ISO RGD:1345643 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SFRP2 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SFRP2 mRNA CTD PMID:34480604